Akums Drugs & Pharmaceuticals Share Price
759.25-21.30 (-2.73%)
+60.16% past 1 Year
Akums Drugs and Pharmaceuticals is a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas. As one of the
Corporate filings & documents
Announcements
Intimation of ESG Rating
21 hours agoIntimation of ESG Rating
21 hours agoIntimation of Schedule of the Investors/Analysts Meet
1 week agoIntimation of Schedule of the Investors/Analysts Meet
1 week agoAkums Drugs and Pharmaceuticals Limited has informed the exchange about an update on schedule of the Investors/ Analysts Meet to be held on August 25 2026
1 week agoAkums Drugs and Pharmaceuticals Limited has informed the exchange about an update on schedule of the Investors/ Analysts Meet to be held on August 25 2026
1 week agoIntimation of Schedule of the Investors/Analysts Meet
3 weeks agoIntimation of Schedule of the Investors/Analysts Meet
3 weeks agoTranscript of Investors/Analysts conference call for the unaudited financial results of Q1 FY 27
3 weeks agoTranscript of Investors/Analysts conference call for the unaudited financial results of Q1 FY 27
3 weeks agoIntimation of Schedule of the Investors/Analysts Meet to be held on August 14 2026
3 weeks agoIntimation of Schedule of the Investors/Analysts Meet to be held on August 14 2026
3 weeks agoLink of audio recording of Investors/Analysts Conference Call
3 weeks agoLink of audio recording of Investors/Analysts Conference Call
3 weeks agoNewspaper Publication
3 weeks agoNewspaper Publication
3 weeks agoMonitoring Agency Report for the quarter ended June 30 2026
3 weeks agoMonitoring Agency Report for the quarter ended June 30 2026
3 weeks agoInvestor Presentation
3 weeks agoInvestor Presentation
3 weeks agoPress Release
3 weeks agoPress Release
3 weeks agoUn-audited Financial Results for the Quarter ended 30th June 2026
3 weeks agoUn-audited Financial Results for the Quarter ended 30th June 2026
3 weeks agoUn-audited Financial Results for the Quarter ended 30th June 2026
3 weeks agoUn-audited Financial Results for the Quarter ended 30th June 2026
3 weeks agoIntimation of schedule of the Analysts/ Investor Conference Call (Group Meet) for un-audited financial results of Q1 FY27
4 weeks agoIntimation of schedule of the Analysts/ Investor Conference Call (Group Meet) for un-audited financial results of Q1 FY27
4 weeks agoIntimation of schedule of the Analysts/ Investor Conference Call (Group Meet) for un-audited financial results of Q1 FY27
4 weeks agoIntimation of schedule of the Analysts/ Investor Conference Call (Group Meet) for un-audited financial results of Q1 FY27
4 weeks agoAkums Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2026 inter alia to consider and approve the un-audited (Standalone & Consolidated) financial results for the quarter ended on 30th June 2026
4 weeks agoAkums Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2026 inter alia to consider and approve the un-audited (Standalone & Consolidated) financial results for the quarter ended on 30th June 2026
4 weeks agoIntimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015- Acquisition of Oriflame Indias Manufacturing Business
1 month agoVoting Results and Scrutinizers Report of the 22nd Annual General Meeting
1 month agoVoting Results and Scrutinizers Report of the 22nd Annual General Meeting
1 month agoProceedings of the 22nd Annual General Meeting of the Company
1 month agoProceedings of the 22nd Annual General Meeting of the Company
1 month agoCertificate pursuant to Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations 2018
1 month agoCertificate pursuant to Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations 2018
1 month agoUpdate on penalty imposed by the Deputy Commissioner of State Tax Gujarat on Maxcure Nutravedics Limited wholly owned subsidiary of the Company
2 months agoUpdate on penalty imposed by the Deputy Commissioner of State Tax Gujarat on Maxcure Nutravedics Limited wholly owned subsidiary of the Company
2 months agoClosure of Trading Window
2 months agoClosure of Trading Window
2 months agoNewspaper Advertisements of the 22nd Annual General Meeting of the Company
2 months agoNewspaper Advertisements of the 22nd Annual General Meeting of the Company
2 months agoNotice and Integrated Annual Report for the Financial Year 2025-26 to those members who have not registered their e-mail IDs
2 months agoNotice and Integrated Annual Report for the Financial Year 2025-26 to those members who have not registered their e-mail IDs
2 months agoBusiness Responsibility and Sustainability Reporting for the FY 2025-26
2 months agoBusiness Responsibility and Sustainability Reporting for the FY 2025-26
2 months agoIntegrated Annual Report for the FY 2025-26
2 months agoAnnual reports
Concalls & investor presentations
Aug 2026
ConcallPresentation
Aug 2026
ConcallPresentation
May 2026
ConcallPresentation
May 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Aug 2025
ConcallPresentation
Aug 2025
ConcallPresentation
May 2025
ConcallPresentation
Feb 2025
ConcallPresentation
Feb 2025
ConcallPresentation
Nov 2024
ConcallPresentation
Nov 2024
ConcallPresentation
Aug 2024
ConcallPresentation
Aug 2024
ConcallPresentation
Corporate Actions
Date
Type
Details
2026-07-03
Dividend
1.0
2026-07-03
Dividend
2.0
Company details
Registered office
304 Mohan Place L S C, Block C Saraswati Vihar New Delhi Delhi PIN: 110034 Tel No: 011- 47511000 Fax No: 011 27023256 Email: [email protected] Internet: www.akums.in
Registrars
PIN: Tel No: Fax No: Email:
Management
Dharamvir Malik, Company Secretary & Compliance Officer
Sanjeev Jain, Managing Director
Sandeep Jain, Managing Director
Sanjay Sinha, Whole Time Director
Sunil Kumar Thakur, Non Executive Director
Kewal Handa, Non Executive Independent Director
Matangi Gowrishankar, Non Executive Independent Director
Satwinder Singh, Non Executive Independent Director
Anil Amin, Non Executive Independent Director
Details
BSE 544222
NSE AKUMS
ISIN INE09XN01023